About Index Trending news
Analyze
Pricing
Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Work at Amplyx Pharmaceuticals, Inc? Add yourself to this profile

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals is developing novel, broadspectrum antifungal agents for the treatment of lifethreatening invasive fungal infections due to candida, aspergillus and rare molds..

Elsewhere

Alexa global traffic share

01 Aug 2017
$67,000,000
Venture capital (Series C)
3x5 Special Opportunity Fund, BioMed Ventures, Sofinnova Ventures, +5

Antifungal biotech Amplyx Pharmaceuticals raises $67 million

sandiegouniontribune.com
+1
10 Feb 2016
$8,700,000
Venture capital (Series B)
3×5 Partners

Amplyx Pharmaceuticals Raises $8.7M Investment from 3×5 Partners

FinSMEs